
VERGANI BARBARA
- U08, Piano: 1I, Stanza: LABORATORIO M.I.A.
Pubblicazioni
Cavaletti, G., Canta, A., Chiorazzi, A., Ballarini, E., Rodriguez, V., Scuteri, A., et al. (2026). Protective effect of new histone deacetylase 6 inhibitors in a cisplatin-induced peripheral neurotoxicity murine model. PAIN REPORTS, 11(2) [10.1097/PR9.0000000000001395]. Dettaglio
Barozzi, D., Scagnoli, F., Barbaglio, F., Belloni, D., Ribezzi, D., Farè, S., et al. (2025). Dynamic stimulation promotes functional tissue-like organization of a 3D human lymphoid microenvironment model in vitro. CELL REPORTS. METHODS, 5(7) [10.1016/j.crmeth.2025.101105]. Dettaglio
Sica, F., Patrucco, M., Giambra, M., Ghizzi, M., Sesana, S., Vergani, B., et al. (2025). Modulation of the blood–brain barrier permeability by patient-derived glioblastoma stem cell secretome. SCIENTIFIC REPORTS, 15(1) [10.1038/s41598-025-21272-3]. Dettaglio
Franchin, M., Vergani, B., Huber, V., Leone, B., Villa, A., Muscato, P., et al. (2025). Proposal of a classification of cannulation damage in vascular access grafts based on clinical, ultrasound, and microscopic observations. JOURNAL OF VASCULAR ACCESS, 26(3), 852-861 [10.1177/11297298241248263]. Dettaglio
Quattrini, G., Barone, C., Muratore, A., Zambelli, G., Timòteo Ferreira, F., Durfort, T., et al. (2025). Embryonic hematopoietic stem and progenitor cells show differential susceptibility to leukemic transformation upon acquisition of JMML-associated KrasG12D mutation. In EHA2025 Abstract Book Poster Session (pp.3125-3127). WILEY [10.1002/hem3.70152]. Dettaglio